Collegium Pharmaceutical (COLL) Amortization - Intangibles (2019 - 2026)

Collegium Pharmaceutical's Amortization - Intangibles history runs 8 years deep, the most recent figure standing at $55.5 million for Q1 2026.

• On a quarterly basis, Amortization - Intangibles changed 0.0% year-over-year to $55.5 million in Q1 2026; TTM through Mar 2026 was $221.9 million, a 19.13% increase from a year earlier, with the FY2025 full-year figure at $221.9 million, up 34.23% from the prior year.
• Amortization - Intangibles was little changed at $55.5 million in Q1 2026 per COLL's latest filing, from $55.5 million in the prior quarter.
• Across five years, Amortization - Intangibles topped out at $55.5 million in Q1 2025 and bottomed at $18.9 million in Q1 2022.
• The 5-year median for Amortization - Intangibles is $37.6 million (2022), against an average of $42.6 million.
• Across the five-year window, Amortization - Intangibles soared 151.74% in 2022 and slipped 18.37% in 2023, its largest moves.
• Year by year, Amortization - Intangibles stood at $42.3 million in 2022, then fell by 18.37% to $34.5 million in 2023, then surged by 60.72% to $55.5 million in 2024, then grew by 0.0% to $55.5 million in 2025, then changed by 0.0% to $55.5 million in 2026.
• Per Business Quant, the three latest COLL Amortization - Intangibles figures stand at $55.5 million (Q1 2026), $55.5 million (Q4 2025), and $55.5 million (Q3 2025).